|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CDKN2B-IGH@ (FusionGDB2 ID:HG1030TG102724971) |
Fusion Gene Summary for CDKN2B-IGH@ |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CDKN2B-IGH@ | Fusion gene ID: hg1030tg102724971 | Hgene | Tgene | Gene symbol | CDKN2B | IGH@ | Gene ID | 1030 | 102724971 |
| Gene name | cyclin dependent kinase inhibitor 2B | putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | |
| Synonyms | CDK4I|INK4B|MTS2|P15|TP15|p15INK4b | IGH|IGHV4|IGHV4-04|IGHV4-4|IGHV@|IGVH|IgA|V4-4b|ighv | |
| Cytomap | ('CDKN2B')('IGH@') 9p21.3 | 15q11.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cyclin-dependent kinase 4 inhibitor BCDK inhibitory proteinCDK4B inhibitorMTS-2cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)cyclin-dependent kinases 4 and 6 binding proteinmultiple tumor suppressor 2p14-INK4bp14_CDK inhibitorp14_INK4B | putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8Ig H-chain V-region (DP-69)Ig heavy chain gene variable region V(11)anti-ZIKV immunoglobulin heavy chain variable regioncirculating B cell antibody heavy chain variable region | |
| Modification date | 20200322 | 20200313 | |
| UniProtAcc | . | . | |
| Ensembl transtripts involved in fusion gene | |||
| Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 0 X 0 X 0=0 |
| # samples | 2 | 0 | |
| ** MAII score | |||